Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
- A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)Active Not Recruiting
Sponsor: Cytokinetics
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
United States, Argentina, Australia, Brazil, Canada +15 more
Sponsor: Hoffmann-La Roche
Metastatic Castration-Resistant Prostate Cancer
United States, Australia, Brazil, Canada, France +7 more
Sponsor: Takeda
Myelofibrosis · Anemia
United States, Argentina, Australia, Austria, Belgium +26 more
Sponsor: Hoffmann-La Roche
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
United States, Australia, China, France, Germany +5 more
- NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast CancerNot Yet Recruiting
Sponsor: Women's Cancer Study Group GmbH
Breast Cancer · Triple-negative Breast Cancer
Germany
Sponsor: LEO Pharma
Atopic Dermatitis · Atopic Hand Eczema
United States, Belgium, Canada, France, Germany +5 more
- A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Australia, Belgium, Brazil, Chile +14 more
Sponsor: Exelixis
Renal Cell Carcinoma (RCC) · Metastatic Castration-Resistant Prostate Cancer (mCRPC) · Urothelial Carcinoma (UC) · Solid Tumor
United States, Australia, Austria, Belgium, France +8 more
Sponsor: Johannes Gutenberg University Mainz
Prediabetes
Germany
Sponsor: Women's Cancer Study Group GmbH
Breast Cancer · HR-positive Breast Cancer · Advanced Breast Cancer · Metastatic Breast Cancer
Belgium, Germany, Portugal
Sponsor: Hoffmann-La Roche
Mature B-Cell Non-Hodgkin Lymphoma
United States, Australia, Brazil, China, Czechia +8 more
Sponsor: Merck Sharp & Dohme LLC
Endometrial Cancer
United States, Argentina, Australia, Austria, Belgium +29 more
Sponsor: Hoffmann-La Roche
Moderately to Severely Active Ulcerative Colitis
United States, Argentina, Australia, Austria, Belgium +25 more
Sponsor: Pliant Therapeutics, Inc.
Idiopathic Pulmonary Fibrosis
United States, Argentina, Australia, Belgium, Brazil +20 more
- A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC PatientsActive Not Recruiting
Sponsor: Jena University Hospital
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Austria, Germany
Sponsor: Exoneural Network AB
Cerebral Palsy · Spasticity · Muscle · Pain Syndrome
Germany
Sponsor: AbbVie
Plaque Psoriasis
Canada, Czechia, France, Germany, Greece +3 more
Sponsor: Hoffmann-La Roche
HER2-positive Breast Cancer
United States, Argentina, Australia, Austria, Belgium +18 more
- A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With TezepelumabActive Not Recruiting
Sponsor: AstraZeneca
Chronic Rhinosinusitis With Nasal Polyps
United States, Bulgaria, Canada, France, Germany +4 more
Sponsor: Hannover Medical School
Acute Kidney Injury
Germany
- Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)Active Not Recruiting
Sponsor: Ipsen
Primary Biliary Cirrhosis
United States, Argentina, Belgium, Brazil, Canada +9 more
- DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine CancersActive Not Recruiting
Sponsor: Boehringer Ingelheim
Neuroendocrine Neoplasms
United States, Belgium, France, Germany, Japan +3 more
Sponsor: VectivBio AG
Short Bowel Syndrome (SBS) · SBS Associated With Intestinal Failure (SBS-IF)
United States, Argentina, Australia, Austria, Belgium +17 more
Sponsor: Evangelisches Klinikum Köln Weyertal gGmbH
Surgery · Obstructive Defecation Syndrome · Mental Health Issue · Depression/Anxiety
Germany
- DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent ChemotherapyActive Not Recruiting
Sponsor: Boehringer Ingelheim
Small Cell Lung Carcinoma (SCLC)
United States, France, Germany, Poland, United Kingdom